Daniel Contreras on 09th Jun

FDA Weighs Pros and Cons of Amgen’s High LDL Cholesterol Drug Repatha before approval

On Monday, the FDA released its review of a new Amgen cholesterol drug ahead of a meeting on Wednesday to consider the drug’s...

Read More